In a 1992 study in rats, the major finding was that intraperitoneal DSIP injection increased the concentration of substance P a neurotransmitter positively correlated with the regulation of anxiety and mood15 in the hypothalamus, suggesting to the researchers that the peptide sharply decreases the classical manifestations of stress.16 Earlier studies in humans, namely a series of five trials published in 1983, came to similar conclusions, with better relaxation and apparently improved tolerance against psychic stress reported by the subjects.17 Its possible that the improved stress and anxiety markers were consequent to DSIP-associated sleep enhancements.18 Substance use recovery A study from 1984 published in European Neurology describes DSIPs potential use as a treatment for alcohol and opiate use disorders
Vitamin B12 Vitamin B12 helps lower inflammation in the body by regulating the amino acid homocysteine
Mix & measure Ipamorelin 10 mg Pre-filled with this protocols recommended BAC water and documented starting dose edit any field to run your own numbers
Additionally, its design limits its affinity for IGF-binding proteins (IGFBPs), which normally restrict IGF-1s activity
PLoS One 12 , e0180578 (2017)
DSIP has a very short plasma half-life, with effects beginning within 10-30 minutes of subcutaneous injection for most users